Olanzapine serum or plasma
Order Name
OLANZ S/P
Test Number: 6905093
Revision Date 12/20/2022
Test Number: 6905093
Revision Date 12/20/2022
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Olanzapine serum or plasma
|
Quant Liquid Chromatography-Tandem Mass Spectrometry | 12389-3 |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 2 mL (0.5 mL) | Serum | Clot Activator SST | Room Temperature |
| Instructions | Specimen Type: Red-top tube OR green-top (heparin) tube. Gel-barrier tubes are NOT recommended. Specimen Storage: SUBMISSION/TRANSPORT (<3 days): Room Temperature. For storage beyond three days, specimen should be refrigerated or frozen. Specimen Collection: Serum or plasma should be separated from cells within two hours of venipuncture. Submit serum or plasma in a plastic transport tube. Special Instructions: Testing referred to MedTox Laboratories Inc MX#756 |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 5-10 days |
| Clinical Use | Olanzapine shows slight interference with high levels of hemolysis in the sample. Noroxycodone causes an analytical interference and impacts the quantitation of Olanzapine |
| Performing Labcorp Test Code | 811513 |
| Notes | Labcorp Test Code: 811513 |
| CPT Code(s) | 80299 |
| Lab Section | Reference Lab |